Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioStorage Launches INTEGRITY Study | Contract Pharma

What are you searching for?

Sign in
Breaking News

BioStorage Launches INTEGRITY Study

Measures long-term integrity of DNA and RNA

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioStorage Technologies has initiated the INTEGRITY Study, a 24-month study analyzing human whole blood samples to measure the impact on the long-term integrity of DNA and RNA when various preparation methods, storage temperatures and storage times are applied.
 
The study will be conducted at the company’s global biorepository in Indianapolis, and will compare fresh samples, frozen pre-extracted samples and extracted nucleic acids, which require freeze/ thaw cycles for processing. Storage temperatures and aliquoting strategies will be evaluated and reported during the study.
 
“The INTEGRITY study has a unique comprehensive study design that will help provide the industry with recommended best practices and techniques to support the optimal preservation of DNA and RNA samples for prospective and retrospective research studies,” said Lori Ball, chief operating officer, BioStorage Technologies. “Our goal is to determine the effects of various preparation methods on whole blood samples for nucleic acid extraction and the optimal length of time and best temperature to store samples for future research.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters